Edwards Lifesciences Corp...

NYSE: EW · Real-Time Price · USD
77.97
-0.21 (-0.27%)
At close: Aug 15, 2025, 9:58 AM

Edwards Lifesciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.05B 1.13B 769M 862.8M
Short-Term Investments
930.7M 500.5M 446.3M 604M
Long-Term Investments
307.9M 583.9M 1.24B 1.83B
Other Long-Term Assets
732.4M 774.3M 299.1M 110.8M
Receivables
727.4M 828.1M 699.1M 664.9M
Inventory
1.09B 903.5M 875.5M 726.7M
Other Current Assets
374.4M 542.5M 195.9M 237.1M
Total Current Assets
6.29B 4.04B 3.1B 3.18B
Property-Plant & Equipment
1.78B 1.68B 1.73B 1.64B
Goodwill & Intangibles
2.95B 1.54B 1.45B 1.49B
Total Long-Term Assets
6.77B 5.33B 5.2B 5.32B
Total Assets
13.06B 9.36B 8.29B 8.5B
Account Payables
197.4M 186.6M 201.9M 204.5M
Deferred Revenue
53.7M n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
442.7M 530.2M 305M 342.7M
Total Current Liabilities
1.51B 1.2B 1.02B 1.03B
Long-Term Debt
597.7M 597M 596.3M 595.7M
Other Long-Term Liabilities
810.6M 786.2M 797.6M 969.6M
Total Long-Term Liabilities
1.49B 1.45B 1.46B 1.63B
Total Liabilities
2.99B 2.64B 2.49B 2.67B
Total Debt
700M 685.1M 691.3M 690.3M
Common Stock
654.8M 650.5M 646.3M 642M
Retained Earnings
13.17B 8.99B 7.59B 6.07B
Comprehensive Income
-244.5M -242.8M -254.9M -157.7M
Shareholders Equity
10B 6.65B 5.81B 5.84B
Total Investments
1.24B 1.08B 1.69B 2.44B